Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Guselkumab in Patients with Scalp Psoriasis: A post hoc Analysis of the VOYAGE 2 Phase III Randomized Clinical Trial
Sonkoly, Enikö, Maul, Julia-Tatjana, Megna, Matteo, Gorecki, Patricia, Crombag, Edmée, Buyze, Jozefien, Savage, Laura
Published in Acta dermato-venereologica (01.01.2024)
Published in Acta dermato-venereologica (01.01.2024)
Get full text
Journal Article
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence
Ruggiero, Angelo, Picone, Vincenzo, Martora, Fabrizio, Fabbrocini, Gabriella, Megna, Matteo
Published in Clinical, cosmetic and investigational dermatology (01.01.2022)
Published in Clinical, cosmetic and investigational dermatology (01.01.2022)
Get full text
Journal Article
Population pharmacokinetics analysis of guselkumab in healthy subjects and patients with psoriatic arthritis, plaque psoriasis and palmoplantar pustulosis
Tran, Lana, Yao, Zhenling, Xu, Zhenhua, Vermeulen, An
Published in British journal of clinical pharmacology (01.10.2022)
Published in British journal of clinical pharmacology (01.10.2022)
Get full text
Journal Article
First-in-human study to assess guselkumab (anti-IL-23 mAb) pharmacokinetics/safety in healthy subjects and patients with moderate-to-severe psoriasis
Zhuang, Yanli, Calderon, Cesar, Marciniak, Stanley J, Bouman-Thio, Esther, Szapary, Philippe, Yang, Tong-Yuan, Schantz, Allen, Davis, Hugh M., Zhou, Honghui, Xu, Zhenhua
Published in European journal of clinical pharmacology (01.11.2016)
Published in European journal of clinical pharmacology (01.11.2016)
Get full text
Journal Article
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial
Haberman, Rebecca H, MacFarlane, Katrina A, Catron, Sydney, Samuels, Jonathan, Blank, Rebecca B, Toprover, Michael, Uddin, Zakwan, Hu, Jiyuan, Castillo, Rochelle, Gong, Cinty, Qian, Kun, Piguet, Vincent, Tausk, Francisco, Yeung, Jensen, Neimann, Andrea L, Gulliver, Wayne, Thiele, Ralf G, Merola, Joseph F, Ogdie, Alexis, Rahman, Proton, Chakravarty, Soumya D, Eder, Lihi, Ritchlin, C T, Scher, Jose U
Published in BMJ open (23.12.2022)
Published in BMJ open (23.12.2022)
Get full text
Journal Article
Abstract CT236: A phase 1b, multicenter, randomized, blinded, placebo-controlled study to evaluate the efficacy of guselkumab in subjects with familial adenomatous polyposis
Vilar-Sanchez, Eduardo, Burke, Carol, Correa, Marcia R. Cruz, Dekker, Evelien, Grady, William M., Grandval, Philippe, Katona, Bryson W., Llor, Xavier, Riegert-Johnson, Douglas L., Saurin, Jean-Christophe, Stanich, Peter, Sussman, Daniel A., Weinberg, David, Attiyeh, Edward F., Joseph, Devanand, Raybold, Kelly, Borzillo, Gary V., Prior, Thomas J., Smith, Michael, Xie, Hong, Bachman, Kurtis E., Infante, Jeffrey R., Samadder, Niloy Jewel
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
P273 Ustekinumab and guselkumab treatment results in differences in serum IL-17A, IL-17F and CRP levels in PsA patients: a comparison from ustekinumab Phase 3 and guselkumab Phase 2 programmes
Siebert, Stefan, Loza, Matthew J, Song, Qingxuan, Gorecki, Patricia C, McInnes, Iain B, Sweet, Kristen
Published in Rheumatology (Oxford, England) (01.04.2020)
Published in Rheumatology (Oxford, England) (01.04.2020)
Get full text
Journal Article
Real-Life Effectiveness and Safety of Guselkumab in Patients with Psoriasis Who Have an Inadequate Response to Ustekinumab: A 3-Year Multicenter Study
Megna, Matteo, Balato, Anna, Caccavale, Stefano, Cacciapuoti, Sara, Calabrese, Giulia, Di Brizzi, Eugenia Veronica, Di Costanzo, Luisa, Manzo, Raffaella, Marino, Vincenzo, Puca, Rosa Valentina, Romano, Francesca, Sarno, Oriele, Scotto di Luzio, Genoveffa, Lembo, Serena
Published in Journal of clinical medicine (01.05.2024)
Published in Journal of clinical medicine (01.05.2024)
Get full text
Journal Article
PASI Improvement in the First 12 weeks from the Phase 3 VOYAGE 1, VOYAGE 2, ORION and ECLIPSE Guselkumab Clinical Trials
Abbarin, Nastaran, Papp, Kim, Vender, Ronald, Langley, Richard, Ho, Vincent, Park-Wyllie, Laura, Miller, Megan, You, Yin, Yang, Ya-Wen
Published in Skin (Milwood, N.Y.) (13.11.2023)
Published in Skin (Milwood, N.Y.) (13.11.2023)
Get full text
Journal Article
Efficacy and safety of guselkumab for the treatment of patients with moderate-to-severe plaque psoriasis: A metaanalysis of randomized clinical trials
Tao, Xing-Bao, Huang, Yin-Qiu, Zhou, Yi-Hong, Zhang, Lv-Lang, Chen, Yao-Kai
Published in Tropical journal of pharmaceutical research (09.04.2020)
Published in Tropical journal of pharmaceutical research (09.04.2020)
Get full text
Journal Article
Information contributed by meta-analysis in exposure–response modeling: application to phase 2 dose selection of guselkumab in patients with moderate-to-severe psoriasis
Hu, Chuanpu, Wasfi, Yasmine, Zhuang, Yanli, Zhou, Honghui
Published in Journal of pharmacokinetics and pharmacodynamics (01.06.2014)
Published in Journal of pharmacokinetics and pharmacodynamics (01.06.2014)
Get full text
Journal Article
Guselkumab Led to Improvements Over Several Psoriatic Arthritis Disease Domains
Get full text
Trade Publication Article